Zohra Benyahia
Overview
Explore the profile of Zohra Benyahia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
158
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
London F, De Haan A, Benyahia Z, Landenne G, Duprez T, van Pesch V, et al.
Acta Neurol Belg
. 2025 Mar;
PMID: 40087234
Background: Cognitive impairment (CI) frequently occurs in relapsing-remitting multiple sclerosis (RRMS) and is assumed to be irreversible. Recent longitudinal studies highlighted the heterogeneity of CI in RRMS, challenging the traditional...
2.
London F, De Haan A, Benyahia Z, Landenne G, Duprez T, van Pesch V, et al.
Mult Scler Relat Disord
. 2023 Jun;
77:104848.
PMID: 37390678
Background: Cognitive impairment (CI) frequently occurs in multiple sclerosis (MS) and is assumed to increase over time. However, recent studies have suggested that the evolution of cognitive status in patients...
3.
London F, Sankari S, De Haan A, Benyahia Z, Landenne G, Duprez T, et al.
Acta Neurol Belg
. 2023 Mar;
123(3):1049-1059.
PMID: 36877357
Background: The added value of patient-reported outcome measures (PROMs) in addition to standard clinical outcome tools in the assessment of relapsing-remitting multiple sclerosis (RRMS) patients' status is increasingly recognized. PROMs...
4.
Benyahia Z, Gaudy-Marqueste C, Berenguer-Daize C, Chabane N, Dussault N, Cayol M, et al.
Cancers (Basel)
. 2022 Dec;
14(23).
PMID: 36497391
Introduction: Metastatic melanoma is an aggressive tumor and can constitute a real therapeutic challenge despite the significant progress achieved with targeted therapies and immunotherapies, thus highlighting the need for the...
5.
Blackman M, Capeloa T, Rondeau J, Zampieri L, Benyahia Z, Van de Velde J, et al.
Cancers (Basel)
. 2022 Sep;
14(18).
PMID: 36139533
Distant metastases are detrimental for cancer patients, but the increasingly early detection of tumors offers a chance for metastasis prevention. Importantly, cancers do not metastasize randomly: depending on the type...
6.
Capeloa T, Krzystyniak J, dHose D, Canas Rodriguez A, Payen V, Zampieri L, et al.
Cancers (Basel)
. 2022 Mar;
14(6).
PMID: 35326667
To successfully generate distant metastases, metastatic progenitor cells must simultaneously possess mesenchymal characteristics, resist to anoïkis, migrate and invade directionally, resist to redox and shear stresses in the systemic circulation,...
7.
Sigaud R, Dussault N, Berenguer-Daize C, Vellutini C, Benyahia Z, Cayol M, et al.
Front Oncol
. 2021 Oct;
11:753244.
PMID: 34692535
VE-cadherin is an essential adhesion molecule in endothelial adherens junctions, and the integrity of these complexes is thought to be regulated by VE-cadherin tyrosine phosphorylation. We have previously shown that...
8.
Benyahia Z, Blackman M, Hamelin L, Zampieri L, Capeloa T, Bedin M, et al.
Cancers (Basel)
. 2021 Feb;
13(3).
PMID: 33540599
To survive and proliferate in solid tumors, cancer cells adapt and evolve rapidly in microenvironments where oxygen and substrate bioavailability fluctuates over time and space. This creates metabolic heterogeneity. Cancer...
9.
Thabault L, Brisson L, Brustenga C, Martinez Gache S, Prevost J, Kozlova A, et al.
J Med Chem
. 2020 Apr;
63(9):4628-4643.
PMID: 32250117
Lactate dehydrogenases (LDHs) are tetrameric enzymes of major significance in cancer metabolism as well as promising targets for cancer therapy. However, their wide and polar catalytic sites make them a...
10.
Capeloa T, Benyahia Z, Zampieri L, Blackman M, Sonveaux P
Semin Cell Dev Biol
. 2019 May;
98:181-191.
PMID: 31112797
Anthracyclines Doxorubicin, Epirubicin, Daunorubicin and Idarubicin are used to treat a variety of tumor types in the clinics, either alone or, most often, in combination therapies. While their cardiotoxicity is...